科美诊断(688468.SH)发预减，预计2025年归母净利润4000万元到4800万元，同比减少62.23%至68.52%

Group 1 - The company, Kemei Diagnostics (688468.SH), announced an expected net profit attributable to shareholders of the parent company for the year 2025 to be between 40 million to 48 million yuan, which represents a year-on-year decrease of 62.23% to 68.52% compared to the previous year [1]